Buprenorphine News

← Back to News Overview


Buprenorphine currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Buprenorphine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Substitution treatment for opioid-drug dependence, within a framework of medical, social and psychological treatment. The intention of the naloxone component is to deter intravenous misuse. Treatment...
  • Evidence level: L5
  • Predicted indications (20):
    • opiate dependence (99.5%)
    • morphine dependence (99.4%)
    • acute intermittent porphyria (99.4%)
    • lingual-facial-buccal dyskinesia (99.3%)
    • chronic tic disorder (99.1%)
    • continuous spikes and waves during sleep (99.0%)
    • extrapyramidal and movement disease (99.0%)
    • benign shuddering attacks (99.0%)
    • schizophreniform disorder (99.0%)
    • schizophrenia (99.0%)
    • benign paroxysmal tonic upgaze of childhood with ataxia (98.9%)
    • psychogenic movement disorders (98.9%)
    • primary orthostatic tremor (98.8%)
    • tremor-nystagmus-duodenal ulcer syndrome (98.8%)
    • drug-induced dyskinesia (98.8%)
    • Charcot-Marie-Tooth disease, demyelinating, type 1G (98.7%)
    • polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (98.7%)
    • retinal dystrophy with or without extraocular anomalies (98.6%)
    • congenital disorder of glycosylation with defective fucosylation (98.6%)
    • hydranencephaly (disease) (98.6%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.